GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study
A new research paper titled "GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells" has been published in Oncotarget.
Feb 27, 2024
0
39
Hemic and Lymphatic Diseases: News and Research on Lymphoma, Non-Hodgkin
MeSH tree: C15.604.515.569.480
New strategy for safer CAR T cell therapy in lymphomas
In treating aggressive lymphomas and blood cancer (leukemia), chimeric antigen receptor T cells (CAR T cells) are increasingly being used. For this therapy, immune cells are taken from patients and programmed by means of ...
Feb 9, 2024
0
82
New technique could make human T cells 100 times more potent at killing cancer cells
Scientists at the UC San Francisco (UCSF) and Northwestern Medicine may have found a way around the limitations of engineered T cells by borrowing a few tricks from cancer itself.
Feb 7, 2024
0
148
Doctors have more difficulty diagnosing disease when looking at images of darker skin: AI may offer a solution
When diagnosing skin diseases based solely on images of a patient's skin, doctors do not perform as well when the patient has darker skin, according to a new study from MIT researchers.
Feb 5, 2024
0
40
Simple blood protein tests predict which lymphoma patients are most likely to have poor CAR T outcomes
As new cancer treatments become available, some of the most important ongoing research must look at ways to optimize those new approaches so that more patients can benefit from groundbreaking therapies. In work published ...
Feb 5, 2024
0
36
Precursor of cholesterol protects cells from ferroptosis, study finds
In a groundbreaking study, a team led by Würzburg Professor José Pedro Friedmann Angeli has shown that the cholesterol precursor 7-dehydrocholesterol (7-DHC) plays a crucial role as an antioxidant: it integrates into the ...
Jan 31, 2024
0
41
Secondary cancers following CAR T cell therapy are rare, analysis shows
The development of any type of second cancer following CAR T cell therapy is a rare occurrence, as found in an analysis of more than 400 patients treated at Penn Medicine. Researchers from the Perelman School of Medicine ...
Jan 25, 2024
0
40
Study finds S. aureus can offset the effect of cancer therapy for Sezáry syndrome
The bacteria Staphylococcus aureus (S. aureus) can worsen the condition of patients with the lymphoma type Sezáry syndrome. A Danish research team has found an underlying mechanism. The improved understanding gives reason ...
Jan 16, 2024
0
32
CAR T cell therapy for T cell lymphoma shows promise in phase I trial
Researchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Houston Methodist Hospital have developed a chimeric antigen receptor (CAR) T-cell therapy targeting T-cell ...
Jan 4, 2024
0
51
Genomic data shed light on how lymphoma can turn lethal
A study by researchers at Columbia and the Hong Kong University of Science and Technology is helping to clarify how low-grade lymphoma changes as it develops into a more aggressive tumor, which could lead to the development ...
Dec 18, 2023
0
62
